If the fund can't earn back this hurdle rate plus the category benchmark average by clever stock selection (or reduce risk significantly), you shouldn't own it.
Nor, the geneticists complained, had there been enough time for natural selection to do its work, given what they had discovered about the rate at which mutations occur, and the fact that most mutations are deleterious.